Repros Therapeutics Inc Financial Statements (2026 and earlier)
Company Profile
| Business Address |
2408 TIMBERLOCH PL WOODLANDS, TX 77380 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2836 - Biological Products, Except Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2017 MRQ | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash, cash equivalents, and short-term investments | 8,688 | 21,393 | 46,620 | 75,807 | 24,212 | |||
| Cash and cash equivalent | 8,688 | 21,393 | 46,620 | 75,807 | 24,212 | |||
| Inventory, net of allowances, customer advances and progress billings | 1,510 | 1,510 | ||||||
| Inventory | 1,510 | 1,510 | ||||||
| Prepaid expense and other current assets | ✕ | ✕ | ✕ | ✕ | ✕ | 406 | ||
| Other undisclosed current assets | 66 | 84 | 289 | (1,321) | (1,510) | |||
| Total current assets: | 8,754 | 21,477 | 46,909 | 75,996 | 24,618 | |||
| Noncurrent Assets | ||||||||
| Property, plant, and equipment, after accumulated depreciation, depletion, and amortization | 3 | 8 | 32 | 75 | 53 | |||
| Intangible asset, including goodwill, after accumulated amortization | 2,906 | 2,161 | ||||||
| Intangible asset, excluding goodwill, after accumulated amortization | 2,906 | 2,161 | ||||||
| Total noncurrent assets: | 3 | 8 | 32 | 2,981 | 2,214 | |||
| TOTAL ASSETS: | 8,757 | 21,485 | 46,941 | 78,977 | 26,832 | |||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities, including: | 2,700 | 2,900 | 2,900 | 3,600 | 3,800 | |||
| Accounts payable | 1,880 | 1,969 | 2,090 | 2,966 | 3,240 | |||
| Accrued liabilities | 779 | 949 | 834 | 586 | 558 | |||
| Other undisclosed accounts payable and accrued liabilities | 41 | (18) | (24) | 48 | 2 | |||
| Other undisclosed current liabilities | (41) | 18 | 24 | (48) | (2) | |||
| Total current liabilities: | 2,659 | 2,918 | 2,924 | 3,552 | 3,798 | |||
| Noncurrent Liabilities | ||||||||
| Total liabilities: | 2,659 | 2,918 | 2,924 | 3,552 | 3,798 | |||
| Equity | ||||||||
| Equity, attributable to parent, including: | 6,098 | 18,567 | 44,017 | 75,425 | 23,034 | |||
| Common stock | 26 | 24 | 24 | 23 | 17 | |||
| Treasury stock, value | (1,380) | (1,380) | (1,380) | (1,380) | (1,380) | |||
| Additional paid in capital | 326,981 | 322,179 | 318,437 | 314,405 | 234,299 | |||
| Accumulated deficit | (319,529) | (302,256) | (273,064) | |||||
| Other undisclosed equity, attributable to parent | (237,623) | (209,902) | ||||||
| Total equity: | 6,098 | 18,567 | 44,017 | 75,425 | 23,034 | |||
| TOTAL LIABILITIES AND EQUITY: | 8,757 | 21,485 | 46,941 | 78,977 | 26,832 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2017 TTM | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|---|---|---|
| Revenues | 47 | 11 | 9 | 9 | 3 | ||
| Gross profit: | 47 | 11 | 9 | 9 | 3 | ||
| Operating expenses | (17,320) | (29,203) | (32,587) | (27,987) | (18,315) | ||
| Other operating income, net (Noninterest Income, Other Operating Income) | 177 | ||||||
| Operating loss: | (17,273) | (29,192) | (32,578) | (27,978) | (18,135) | ||
| Nonoperating income (Investment Income, Nonoperating) | 9 | 9 | 3 | ||||
| Loss from continuing operations: | (17,273) | (29,192) | (32,569) | (27,969) | (18,132) | ||
| Loss before gain (loss) on sale of properties: | (17,273) | (29,192) | (32,569) | (27,969) | (18,132) | ||
| Net loss: | (17,273) | (29,192) | (32,569) | (27,969) | (18,132) | ||
| Other undisclosed net income (loss) attributable to parent | 34 | 248 | (35) | ||||
| Net loss available to common stockholders, diluted: | (17,273) | (29,192) | (32,535) | (27,721) | (18,167) | ||
Comprehensive Income ($ in thousands)
| 9/30/2017 TTM | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|---|---|---|
| Net loss: | (17,273) | (29,192) | (32,569) | (27,969) | (18,132) | ||
| Comprehensive loss, net of tax, attributable to parent: | (17,273) | (29,192) | (32,569) | (27,969) | (18,132) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.